As families head into a season full of parties, toasts and holiday dinners, a new study offers a reason for people being treated for cancer to talk with their care team about drinking. Researchers at the University of North Carolina at Chapel Hill report that regular alcohol use appeared to weaken a widely used type of cancer immunotherapy in mice, and that heavier drinkers in a group of patients had poorer survival after starting similar treatment.
The study, led by Kristen Gilley of UNC’s Bowles Center for Alcohol Studies, was published this week in the journal Science Signaling, according to a release from the journal’s publisher, AAAS.
What the researchers found
The team focused on anti-PD-1 therapy, one kind of “immune checkpoint inhibitor.” These medicines are designed to take the brakes off the immune system so its T cells can better attack tumors.
In mice with lung or bladder cancer, researchers gave a moderate-to-heavy amount of alcohol, roughly equal to three to six drinks a day for a person, along with the immunotherapy. According to the AAAS release and News-Medical, the treatment worked about half as well in those mice, and the risk of tumors coming back went up.
The researchers also looked at why. Alcohol reduced the numbers of tumor-fighting and “memory” T cells and increased T cells carrying TIGIT, a protein that acts as a brake on immune activity. ThePrint reported that alcohol also shifted the balance of certain other T-cell types. When the scientists blocked TIGIT with an antibody, the immunotherapy’s effectiveness was restored in the mice.
In a separate look back at patient records, people with skin, lung, bladder or head and neck cancer who reported eight or more drinks a week had poorer survival after beginning checkpoint inhibitor treatment.
Important limits
This is early research, and it does not prove that drinking caused worse outcomes in people. The clearest results came from mice, which do not always respond the way humans do. The patient analysis was retrospective and relied on people reporting their own drinking, which can show a link but not cause and effect. The coverage reviewed by Upstormed News did not report how many patients were included.
The authors themselves describe the work as an “initial resource toward establishing the risk of regular alcohol use” during this kind of treatment. They suggest that cancer databases begin recording patients’ alcohol use so researchers can better understand its effects on other therapies, too.
Why it matters
Doctors often advise people with cancer to avoid alcohol, yet the AAAS release notes that recent studies have found as many as 76.4% of patients still drink. Medical groups have called for more research on how alcohol affects treatment results. This study adds one of the first detailed explanations of how alcohol might interfere with the immune response these drugs depend on.
Why it matters for families
The holidays can make it harder to say no to a glass of wine or a cocktail, and loved ones may not realize that drinking could matter during cancer care. This is general information, not medical advice. Some practical steps:
- If you or a family member is receiving immunotherapy or any cancer treatment, talk with your doctor or oncology team about alcohol, including how much, if any, is safe for you.
- Do not stop or change any treatment on your own because of a news report.
- Hosts can make gatherings easier by offering tasty alcohol-free drinks so no one feels left out.
- Support, not pressure, helps: a quiet “there is sparkling cider too” can mean a lot to someone in treatment.
What to watch next
The findings point to TIGIT as a possible target for future research, and larger studies in people will be needed to confirm whether alcohol changes how well immunotherapy works. Upstormed News will follow this research as more results are published.
Related coverage: Vatican’s Christmas Tree Arrives as Advent Nears; Children With Cancer Will Light It · Justice’s ‘Grand Theft Auto VI’ Score Arrives Dec. 11: Tracks, Features and a Family Listening Guide
Read more: A Thankful Heart, a Healthier Life? What New Gratitude Research Suggests
Do you offer alcohol-free drink options at your holiday gatherings? Share your favorite recipe.
Sources: EurekAlert!/AAAS, “New study may explain how drinking alcohol weakens the tumor-killing capabilities of cancer immunotherapy” (November 17, 2026); News-Medical, “Researchers reveal how regular alcohol use impairs the effectiveness of cancer immunotherapy” (November 18, 2026); ThePrint, “Alcohol alters immune cells that fight cancer. Here’s how” (November 18, 2026)





Leave a Reply